TIL

28.44

2.97% 0.82

Handel nachbörslich: 28.45 0.010 +0.04%

Instil Bio Inc (TIL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$27.62

Offen:

$28.12

24-Stunden-Volumen:

152.84K

Relative Volume:

0.48

Marktkapitalisierung:

$186.54M

Einnahmen:

Nettoeinkommen (Verlust:

$-74.14M

KGV:

-2.4969

EPS:

-11.39

Netto-Cashflow:

$-65.70M

1W Leistung:

+19.15%

1M Leistung:

+2.67%

6M Leistung:

+44.22%

1J Leistung:

+122.19%

1-Tages-Spanne:

$26.31

$29.06

1-Wochen-Bereich:

$22.73

$29.06

52-Wochen-Spanne:

$9.85

$92.00

Instil Bio Inc Stock (TIL) Company Profile

Firmenname

Instil Bio Inc

Sektor

Healthcare (1161)

Branche

Biotechnology (653)

Telefon

(972) 499-3350

Adresse

3963 MAPLE AVENUE, DALLAS

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-11

Neueste SEC-Einreichungen

TIL's Discussions on Twitter

Vergleichen Sie TIL mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TIL Instil Bio Inc	28.44	156.59M	0	-74.14M	-65.70M	-11.39
VRTX Vertex Pharmaceuticals Inc	470.13	119.21B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	560.93	59.16B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	325.28	40.57B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	571.23	34.02B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	295.59	29.19B	3.81B	-644.79M	-669.77M	-6.24

Instil Bio Inc Stock (TIL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-01-07	Hochstufung	Jefferies	Hold → Buy
2024-11-04	Eingeleitet	JMP Securities	Mkt Perform
2024-04-12	Herabstufung	Jefferies	Buy → Hold
2022-11-01	Herabstufung	Cowen	Outperform → Market Perform
2022-11-01	Herabstufung	Truist	Buy → Hold
2021-08-13	Eingeleitet	Robert W. Baird	Outperform
2021-04-13	Eingeleitet	Cowen	Outperform
2021-04-13	Eingeleitet	Morgan Stanley	Equal-Weight
2021-04-13	Eingeleitet	Truist	Buy

Alle ansehen

Instil Bio Inc Aktie (TIL) Neueste Nachrichten

Jul 22, 2025

What drives Instil Bio Inc. stock priceExceptional portfolio growth - jammulinksnews.com

Jul 22, 2025

Instil Bio Inc. Stock Analysis and ForecastExplosive earning power - jammulinksnews.com

Jul 22, 2025

Is Instil Bio Inc. a good long term investmentConsistent high-performance stocks - jammulinksnews.com

Jul 22, 2025

What analysts say about Instil Bio Inc. stockFree Buy/Sell Signal Notifications - jammulinksnews.com

Jul 22, 2025

Jul 20, 2025

Will Instil Bio Inc. stock benefit from interest rate changesSolid Return Trade Selections - Newser

Jul 20, 2025

(TIL) Proactive Strategies - news.stocktradersdaily.com

Jul 20, 2025

Jul 18, 2025

When is the best time to buy Instil Bio Inc. stockEntry Level Low Risk Picks - Newser

Jul 18, 2025

Jul 15, 2025

Why Instil Bio Inc. stock attracts strong analyst attentionProtected Capital Trading Plan - Newser

Jul 15, 2025

What makes Instil Bio Inc. stock price move sharplyFree Consultation - Newser

Jul 15, 2025

How Instil Bio Inc. stock performs during market volatilityTop Growth Low Risk Stocks - Newser

Jul 15, 2025

Jul 02, 2025

Instil Bio stock jumps after FDA clearance of IND application - Investing.com

Jul 02, 2025

Instil Bio stock jumps after FDA clearance of IND application By Investing.com - Investing.com UK

Jul 02, 2025

Instil Bio, Inc. Announces U.S. F.D.A. Clearance of Investigational New Drug Application for AXN-2510 - MarketScreener

Jul 02, 2025

FDA clears Instil Bio’s IND for AXN-2510 cancer therapy - Investing.com

Jul 02, 2025

Jun 30, 2025

Instil Bio: Chasing After Summit And BioNTech, Albeit With Some Hiccups - Seeking Alpha

Jun 30, 2025

Jun 20, 2025